NO952532L - Steroidforbindelser - Google Patents

Steroidforbindelser

Info

Publication number
NO952532L
NO952532L NO952532A NO952532A NO952532L NO 952532 L NO952532 L NO 952532L NO 952532 A NO952532 A NO 952532A NO 952532 A NO952532 A NO 952532A NO 952532 L NO952532 L NO 952532L
Authority
NO
Norway
Prior art keywords
hydrogen
halogen
position forms
alkoxy
double bond
Prior art date
Application number
NO952532A
Other languages
English (en)
Norwegian (no)
Other versions
NO952532D0 (no
Inventor
Michael John Ashton
Sven Jan-Anders Karlsson
Bernard Yvon Jack Vacher
Michael Thomas Withnall
Original Assignee
Rhone Poulenc Rorer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929226917A external-priority patent/GB9226917D0/en
Priority claimed from GB939303121A external-priority patent/GB9303121D0/en
Application filed by Rhone Poulenc Rorer Ltd filed Critical Rhone Poulenc Rorer Ltd
Publication of NO952532D0 publication Critical patent/NO952532D0/no
Publication of NO952532L publication Critical patent/NO952532L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0092—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by an OH group free esterified or etherified

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO952532A 1992-12-24 1995-06-23 Steroidforbindelser NO952532L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB929226917A GB9226917D0 (en) 1992-12-24 1992-12-24 Novel compositions of matter
GB939303121A GB9303121D0 (en) 1993-02-17 1993-02-17 Novel compositions of matter
PCT/GB1993/002659 WO1994014834A1 (en) 1992-12-24 1993-12-24 New steroids

Publications (2)

Publication Number Publication Date
NO952532D0 NO952532D0 (no) 1995-06-23
NO952532L true NO952532L (no) 1995-08-24

Family

ID=26302221

Family Applications (1)

Application Number Title Priority Date Filing Date
NO952532A NO952532L (no) 1992-12-24 1995-06-23 Steroidforbindelser

Country Status (19)

Country Link
US (1) US5801165A (de)
EP (1) EP0675897B1 (de)
JP (1) JP2657982B2 (de)
KR (1) KR960700265A (de)
AT (1) ATE154607T1 (de)
AU (1) AU672669B2 (de)
CA (1) CA2149777C (de)
CZ (1) CZ159195A3 (de)
DE (1) DE69311742T2 (de)
DK (1) DK0675897T3 (de)
ES (1) ES2107806T3 (de)
FI (1) FI953130A0 (de)
GR (1) GR3024641T3 (de)
HU (1) HUT72442A (de)
IL (1) IL108167A0 (de)
NO (1) NO952532L (de)
NZ (1) NZ259401A (de)
PL (1) PL309402A1 (de)
WO (1) WO1994014834A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9507135D0 (en) * 1995-04-06 1995-05-31 Rh Ne Poulenc Rorer Limited Chemical compounds
ATE195529T1 (de) * 1995-12-29 2000-09-15 Glaxo Group Ltd 17beta-(2-oxo-tetrahydrofuran-4-yl)-thio- androstane derivate (17beta-(gamma-buttersäure- lacton)-thio derivate) zur behandlung von entzündungen, pharmazeutische präparate davon und ein verfahren zu ihrer herstellung
JP4228116B2 (ja) * 1996-05-09 2009-02-25 ゼニス・オペレイションズ・プロプライエタリー・リミテッド 喘息および気道の疾患の治療
HRP20010018A2 (en) 2001-01-09 2002-12-31 Pliva D D Novel anti-inflammatory compounds
AU2003255851B2 (en) 2002-07-08 2009-07-23 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. New compounds, compositions and methods for treatment of inflammatory diseases and conditions
EP1551865B1 (de) 2002-07-08 2009-04-22 GlaxoSmithKline istrazivacki centar Zagreb d.o.o. Hybridmoleküle von makroliden mit steroidalen/nicht-steroidalen antientzündlich aktiven molekülen
HRP20030324A2 (en) 2003-04-24 2005-02-28 Pliva-Istra�iva�ki institut d.o.o. Compounds of antiinflammatory effect
HRP20030603A2 (en) 2003-07-25 2005-10-31 Pliva-Istra�iva�ki institut d.o.o. Substituted furochromene compounds of antiinflammatory action
HRP20030604A2 (en) 2003-07-25 2005-04-30 Pliva-Istra�iva�ki institut d.o.o. Substituted furochromenes, preparation thereof andtheir antiinflammatory action
US20090048221A1 (en) 2004-10-27 2009-02-19 Mladen Mercep Conjugates with Anti-Inflammatory Activity
GB0520794D0 (en) * 2005-10-12 2005-11-23 Innovata Biomed Ltd Inhaler
PT105138B (pt) * 2010-06-01 2012-11-06 Hovione Farmaciencia S A Método para a preparação de compostos orgânicos monofluorometilados biologicamente activos
PT105723B (pt) * 2011-05-26 2014-03-24 Hovione Farmaci Ncia S A Método para a preparação de compostos orgânicos biologicamente activos

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3198792A (en) * 1962-06-12 1965-08-03 Philips Corp 10alpha methyl, 9beta hormonal steroids
SE378109B (de) * 1972-05-19 1975-08-18 Bofors Ab
US4933168A (en) * 1975-05-27 1990-06-12 Syntex Pharmaceuticals International Limited Stable, crystalline flunisolide
US4188385A (en) * 1978-04-05 1980-02-12 Syntex (U.S.A.) Inc. Thioetianic acid derivatives
GB2137206B (en) * 1980-02-15 1985-04-03 Glaxo Group Ltd Androstane 17-carbothioc acid derivatives
SE8008524L (sv) * 1980-12-04 1982-06-05 Draco Ab 4-pregnen-derivat, ett forfarande for deras framstellning, beredning och metod for behandling av inflammatoriska tillstand
US4361559A (en) * 1981-08-20 1982-11-30 E. R. Squibb & Sons, Inc. Antiinflammatory 17,17-bis (substituted thio) androstenes
HU182775B (en) * 1981-10-15 1984-03-28 Richter Gedeon Vegyeszet Process for preparing new 3-chloro-pregnane derivatives
US4481144A (en) * 1984-02-03 1984-11-06 E. R. Squibb & Sons, Inc. 17-Substituted thia-17-alkyl(or alkenyl or alkynyl)androstenes
US4499021A (en) * 1984-04-12 1985-02-12 E. R. Squibb & Sons, Inc. 17β(Substituted thio)-16-ketoandrostene-17α..-carboxylic acid derivatives
US4528138A (en) * 1984-06-20 1985-07-09 E. R. Squibb & Sons, Inc. 16-Keto-17-substituted thia-17-alkyl(or alkenyl or alkynyl) androstenes
US4529547A (en) * 1984-06-20 1985-07-16 E.R. Squibb & Sons, Inc. 17-(substituted thio)-17-(substituted dithio)androstenes
SE8501693D0 (sv) * 1985-04-04 1985-04-04 Draco Ab Novel 16,17-acetalsubstituted androstane-17beta-carboxylic acid esters
US4868170A (en) * 1987-11-13 1989-09-19 E. R. Squibb & Sons, Inc. Steriod lotion formulation
US4868169A (en) * 1987-11-13 1989-09-19 E. R. Squibb & Sons, Inc. Steroid cream formulation
US4883792A (en) * 1989-01-17 1989-11-28 Peter Timmins Steroid cream formulation

Also Published As

Publication number Publication date
IL108167A0 (en) 1994-04-12
FI953130A7 (fi) 1995-06-22
ATE154607T1 (de) 1997-07-15
ES2107806T3 (es) 1997-12-01
JPH08504806A (ja) 1996-05-28
HU9501876D0 (en) 1995-08-28
EP0675897B1 (de) 1997-06-18
US5801165A (en) 1998-09-01
AU5819694A (en) 1994-07-19
FI953130L (fi) 1995-06-22
EP0675897A1 (de) 1995-10-11
NO952532D0 (no) 1995-06-23
PL309402A1 (en) 1995-10-02
CA2149777A1 (en) 1994-07-07
HUT72442A (en) 1996-04-29
DK0675897T3 (da) 1998-01-26
JP2657982B2 (ja) 1997-09-30
KR960700265A (ko) 1996-01-19
CA2149777C (en) 2004-05-25
AU672669B2 (en) 1996-10-10
GR3024641T3 (en) 1997-12-31
DE69311742D1 (de) 1997-07-24
WO1994014834A1 (en) 1994-07-07
NZ259401A (en) 1996-10-28
CZ159195A3 (en) 1996-03-13
FI953130A0 (fi) 1995-06-22
DE69311742T2 (de) 1998-01-08

Similar Documents

Publication Publication Date Title
NO20003514L (no) Hypolipidemiske benzothiazepin-forbindelser
HU9402365D0 (en) Hypolipidaemic benzothiazepine compounds
DK76784A (da) N-phenyl-benzamidderivater, fremgangsmaade til fremstilling heraf samt deres anvendelse til bekaempelse af sygdomme i immunsystemet
NO823836L (no) Fremgangsmaate ved fremstilling av antifibrinolytisk aktive forbindelser.
DE2960820D1 (en) Carbostyrile derivatives, processes for their preparation and pharmaceutical compositions containing them
DE69728544D1 (de) Totalsynthese von acylfulvenen mit antitumorwirkung
IE810654L (en) Azetidinone derivatives.
PT98362A (pt) Processo para a preparacao de derivados de tioalquiltio-cefalosporina e de composicoes farmaceuticas que os contem
NO943895L (no) Galantaminderivater, en fremgangsmåte for fremstilling samt deres anvendelse som medikamenter
EP0675897A1 (de) Neue steroide.
AU699091B2 (en) Novel naphthyridine derivatives
DK0515264T3 (da) Hidtil ukendte steroid-derivater af pregna-4,9(11),17(20)-trien-3-on, deres fremstilling, deres anvendelse til fremstilling af steroidforbindelser af typen pregna-4,9(11),16-trien-3,20-dion samt hidtil ukendte mellemprodukter
NZ246598A (en) Trazodone derivatives; compounds and preparation, pharmaceutical compositions; intermediate compounds
FI896251A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten pyratsolopyridiinijohdannaisten valmistamiseksi
DK32789D0 (da) Derivat af antibiotikum
NO934791L (no) Cefalosporinsalter og fremgangsmåte for fremstilling derav
IT1150955B (it) Derivati 3h-naft(1.2-d)-imidazolici il procedimento per la loro preparazione, il loro uso come agenti antiinfiammatori e le composizioni farmaceutiche che li contengono
AU535774B2 (en) Thiazole derivatives their preparation and pharmaceutical compositions containing them
AU617849B2 (en) New benzopyrrolidinone derivatives, a process for the preparation thereof and pharmaceutical compositions containing them
NO971196L (no) Epimerer av (22RS)-N-(1,1,1-trifluor-2-fenylprop-2-yl)-3-okso-4-aza-5<alfa>-androst-1-en-17<beta>-karboksamid
AU657423B2 (en) Novel piperidine derivatives and process for preparation thereof
IE813082L (en) Cis-c3",c4"-carbonate derivatives of oleandomycin-y
IL97611A (en) Heterocyclic compounds, their preparation and pharmaceutical compositions containing them
AU566389B2 (en) (2,3-b) thieno pyrrole derivatives
AU6754887A (en) Novel pregnane derivatives, processes for their preparation and pharmaceutical compositions containing same